Micafungin sodium

DRUG2 trials

Sponsors

Yonsei University, Shandong Provincial Hospital

Conditions

Febrile NeutropeniaHematological DiseasesHematological Tumors Patients With High Risk Factors of Invasive Fungal Disease

Phase 2

Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases

CompletedNCT01344681

Yonsei UniversityFebrile Neutropenia, Hematological Diseases

Start: 2011-06-30End: 2014-03-31Updated: 2014-12-08

Phase 4

Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors

Shandong Provincial HospitalHematological Tumors Patients With High Risk Factors of Invasive Fungal Disease

Start: 2021-02-01End: 2023-10-01Target: 230Updated: 2021-02-04